IFF — Third Quarter 2026 Earnings Summary

IFF reported third-quarter 2026 net sales of $1.94 billion, representing a 4% increase over the prior year, with adjusted operating EBITDA reaching $403 million. The company raised its full-year 2026 sales guidance to a range of $7.5 billion to $7.6 billion and adjusted operating EBITDA guidance to $1.55 billion to $1.60 billion. Segment performance showed growth across Taste, Health & Biosciences, and Scent, driven by volume increases and favorable pricing. Additionally, IFF completed a $500 million share repurchase authorization and confirmed that the divestiture of its Food Ingredients business remains on track for closure by the end of the second quarter of 2027.